EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Papaverine in the treatment of erectile dysfunction 2 1 2 years' experience



Papaverine in the treatment of erectile dysfunction 2 1 2 years' experience



Schweizerische Medizinische Wochenschrift 118(30): 1099-1103



The physiological basis of erectile function is described and the possibilities and limits of therapy with intracavernous papaverine are discussed. It is of extreme importance that, whenever possible, patients should perform self-injections at home. Thus, 20% of our patients regained potency after a few self-injections. Another 40% practiced selfinjections as long-term treatment.

(PDF 0-2 workdays service: $29.90)

Accession: 006059927

Download citation: RISBibTeXText



Related references

Therapy of erectile dysfunction using papaverine--2 1/2 years' experience. Schweizerische Medizinische Wochenschrift 118(30): 1099-1103, 1988

Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction. Der Urologe. Ausg. A 27(1): 22-26, 1988

Experience in the treatment of erectile dysfunction using the intracavernosal self injection of papaverine results of a prospective study after a median follow up of 42 months involving 135 patients and 10766 injections. World Journal of Urology 10(3): 179-182, 1992

Experience with intracorporal prostaglandin E1, papaverine and phentolamine in patients with erectile dysfunction. Journal of Urology 149(4 SUPPL ): 346A, 1993

Papaverine topical gel for treatment of erectile dysfunction. Journal of Urology 153(2): 361-365, 1995

Comparative usefulness of prostaglandin e 1 papaverine and papaverine phentolamine for the diagnosis of erectile dysfunction in 61 patients. Urologe Ausgabe A 27(1): 22-26, 1988

Topical papaverine gel for treatment of erectile dysfunction-Preliminary study. Journal of Urology 151(5 SUPPL ): 346A, 1994

Comparison of prevalence between self-reported erectile dysfunction and erectile dysfunction as defined by five-item International Index of Erectile Function in Taiwanese men older than 40 years. Urology 69(4): 743-747, 2007

Re: Can simvastatin improve erectile function and health-related quality of life in men aged ≥40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971. Journal of Urology 188(5): 1871-1872, 2012

Can simvastatin improve erectile function and health-related quality of life in men aged ≥40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971. Bju International 111(2): 324-333, 2013

Can simvastatin improve erectile function and health-related quality of life in men aged >40 years with erectile dysfunction? Rationale and design of the Erectile Dysfunction and Statins (EDS) Trial [ISRCTN66772971](1). Bju International 108(11): 1850-1854, 2011

Efficacies of papaverine and sildenafil in the treatment of erectile dysfunction in early-stage paraplegic men. International Journal of Rehabilitation Research. Internationale Zeitschrift für Rehabilitationsforschung. Revue Internationale de Recherches de Readaptation 34(1): 44-52, 2011

Intracorporeal three drug combination treatment in erectile dysfunction Comparison to papaverine-phentolamine and prostaglandin E1 alone. Journal of Urology 149(4 SUPPL ): 346A, 1993

Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male. Urology 40(1): 36-40, 1992

Erectile dysfunction after kidney transplantation: our 22 years of experience. Journal of Urology 173(3): 930-931, 2005